NCT02432937 - Corever in the Treatment of Hypertension | Biotech Hunter

Enrollment

134

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

August 31, 2016

Conditions

Hypertension

Interventions

DRUG

Corever

Trial Locations (8)

Hualien Tzu Chi Hospital, Hualien City

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City

Chung Shan Medical University Hospital, Taichung

Taichung Veterans General Hospital, Taichung

National Taiwan University Hospital, Taipei

Shin Kong Wu Ho-Su Memorial Hospital, Taipei

Taipei Veterans General Hospital, Taipei

All Listed Sponsors

lead

TSH Biopharm Corporation Limited

INDUSTRY